Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Novatek connected a new gas carrier for LNG transshipment in Murmansk

1/30/25 NVTK

Moscow Exchange will launch an index of shareholder value creation for companies

1/30/25 MOEX

Sollers launched a full cycle of production of pickup trucks ST6 and ST8

1/30/25 SVAV

Sollers raised the Net Debt/ EBITDA threshold for dividends

1/30/25 SVAV

Fix Price in 2025 plans in Kazakhstan to open at least 60 stores

1/30/25 FIXP

Rusal will double capacity to produce aluminum powders and pastes

1/30/25 RUAL

Fesco increased container transportation between India and Novorossiysk by 7 times

1/30/25 FESH

Ozone Pharmaceuticals completed monolithic works at Ozone Medica

1/30/25 OZPH

MD Medical opened a clinic in Khabarovsk

1/30/25 MDMG

LSR invested ₽27 billion in the construction and renovation of two sanatoriums in Sochi

1/29/25 LSRG